Pollogen Will Showcase Its Advanced Anti-Aging Solutions- the Surgen and the geneO+ Systems at the Upcoming AMWC Meeting in Monaco

Surgen uses cutting-edge Hybrid Energy and TriFractional Technology to deliver pain free skin resurfacing treatments and the geneO+ is a 3-in-1 Super Facial platform powered by OxyGeneo technology. Pollogen's wide product offering ensures that aesthetic professionals have the treatment solutions that best meet their needs.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Hybrid Energy technology is a breakthrough anti-aging technology

Hybrid Energy is non-surgical technology, with minimal discomfort and no downtime

Hybrid Energy demonstrated significant skin refilling along with improvement of skin texture and irregularities. No adverse effects were detected and treatments were well tolerated by patients with none to minimal pain and no down time.

Tel-Aviv, Israel (PRWEB) April 01, 2014

Pollogen Ltd., a global leader in the medical aesthetic market, will be exhibiting at the upcoming 12th Anti-Aging Medicine World Congress in Monte-Carlo, Monaco, held on 3-5 April 2014. Booth # B1.

Pollogen will be showcasing the Surgen system- an advanced dual technology platform for physicians that combines Hybrid Energy technology and TriFractional technology. Hybrid Energy technology was specifically developed to work with the body’s natural mechanism to promote wrinkle reduction, skin volumizing, stretch marks and acne scars improvement, without the need for surgery. Treatment is virtually painless and suitable for all skin types and colors. TriFractional technology is an advanced anti-aging sophisticated pulse sequence radio frequency solution that enables effective fractional skin resurfacing and is suitable for enhancing the Hybrid Energy treatment. The Surgen platform has a user friendly touch screen with pre-programmed and adjustable parameters for each treatment type.

Click here to see how Hybrid Energy technology works.

Dr. Ghislaine Beilin, Vice President of the Federation of Aesthetic Medicine and Anti-Aging (Fédération Syndicale des Médecines Esthétiques et Anti-Age), will lecture at the AMWC on her experience with Hybrid Energy technology. The lecture entitled "Hybrid Energy Technology- an emerging advancement in fractional radio frequency technology" will take place on Friday, April 4th at 8:30 am in the Van Dongen room.

Dr. Beilin stated: "In my findings, Hybrid Energy demonstrated significant skin refilling along with improvement of skin texture and irregularities. No adverse effects were detected and treatments were well tolerated by patients with none to minimal pain and no down time."

Pollogen will also be featuring the geneO+- its advanced solution for spas and beauty salons. Powered by OxyGeneo technology, the geneO+ simultaneously performs three skin rejuvenation actions - gentle skin exfoliation, infusion of essential revitalizing nutrients and natural skin oxygenation. The oxygenation occurs from within the skin since the geneO+ triggers a body response called the "Bohr Effect" that results in the body sending oxygen to the treated area. This oxygenation process significantly increases the effectiveness of the treatment. The geneO+ treatment is fast and effective and softens fine lines and wrinkles, minimizes pore size, revitalizes dull complexion and provides a balanced healthy look. The geneO+ solution is suitable for all skin types and colors and results are visible after the very first session.

Click here to see how Oxygeneo works.

Janina Olszewska from Janina’s Esthetics in Toronto Canada is a real geneO+ fan: “geneO+ is working out like no other device I've ever bought. I was able to pay it off in 2 months. My clients are extremely satisfied with their results, noticing diminished lines and lighter pigmentation marks, less break outs and smoother skin. I had few clients calling me the day after the treatment and thanking me for the outcome”.

Mr. Amichai Bar-Nir, Pollogen's CEO stated: The Anti-Aging Medicine World Congress in Monaco is an important event for aesthetic practitioners which sets the tone for the industry. Pollogen has performed clinical trials with Dr. Beilin for many years and we are delighted by the results of her study which further confirm the safety and effectiveness of the Surgen system. We are very excited to showcase the Surgen and geneO+ systems and are confident that skin care specialists will be impressed by the anti-aging results they deliver."

About Pollogen

We believe in constantly challenging ourselves to create the most advanced, effective medical aesthetic technologies and solutions. We believe in thinking differently.

In everything we do, we take a customer-centric approach by making our products user-friendly, safe and convenient. At Pollogen there is no such word as “done”; we continually perfect our solutions to provide treatments that are pleasant and effective. We believe in finding ways to develop technologies that work with the body’s natural mechanisms so beautiful results are generated from within.

Pollogen is the developer and manufacturer of six revolutionary technologies under the industry premier brand names OxyGeneo™, Hybrid Energy™, VoluDerm™, TriPollar®, TriLipo® and TriFractional™. We offer a full line of clinically-proven, safe and effective, non-invasive anti-aging facial and body contouring treatment platforms for a wide range of aesthetic applications. Pollogen provides solutions for professionals in over 60 countries, addressing the specific needs and dynamic changes unique to the ever-evolving aesthetic industry.